Imaging the Biodistribution of the Positron Emission Tomography Reporter Probe, [18F]FHBG, in Humans.
The success of cell and gene therapy depends on specific targeting of the therapeutic gene
or cell that is administered to the patient. Our goal is to develop an imaging method to
non-invasively monitor the location of the therapeutic gene or cell. Imaging should help in
the design of better protocols and potentially reduce side-effects of cell and gene therapy.
Observational Model: Cohort, Time Perspective: Prospective
The primary endpoint of the study for each patient is acquisition of PET/CT image.
Time of scan
Sanjiv Sam Gambhir M.D., Ph.D.
United States: Food and Drug Administration
|Stanford University School of Medicine||Stanford, California 94305-5317|
|University of California Los Angeles||Los Angeles, California 90095-6951|